4.1 Article

Real-life cost of vitamin K antagonist treatment in patients with non-valvular atrial fibrillation in France in 2013

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

French health insurance databases: What interest for medical research

G. Moulis et al.

REVUE DE MEDECINE INTERNE (2015)

Article Hematology

Differences among western European countries in anticoagulation management of atrial fibrillation

Jean-Yves Le Heuzey et al.

THROMBOSIS AND HAEMOSTASIS (2014)

Review Cardiac & Cardiovascular Systems

ARISTOTLE RE-LYs on the ROCKET. What's new in stroke prevention in patients with atrial fibrillation?

Michal Tendera et al.

CARDIOLOGY JOURNAL (2012)

Article Public, Environmental & Occupational Health

Pharmacoepidemiological research using French reimbursement databases: yes we can!

Karin Martin-Latry et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)

Article Public, Environmental & Occupational Health

French national health insurance information system and the permanent beneficiaries sample

P. Tuppin et al.

REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2010)

Article Economics

The impact of atrial fibrillation on the cost of stroke:: The Berlin acute stroke study

Bernd Brueggenjuergen et al.

VALUE IN HEALTH (2007)

Review Hematology

Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review

T. . D. Szucs et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)

Article Cardiac & Cardiovascular Systems

Cost of care distribution in atrial fibrillation patients: The COCAF study

JY Le Heuzey et al.

AMERICAN HEART JOURNAL (2004)